Literature DB >> 14696819

Ovarian cancer--the need for change in service delivery in Northern Ireland.

W N Irvine1, R J Middleton, A T Gavin, D A Fitzpatrick.   

Abstract

This paper provides local data on the provision of services for patients diagnosed with ovarian cancer in 1996 prior to the reorganisation of cancer services. It documents a service for 140 patients provided by 80 consultant teams and illustrates the need for reorganisation to meet the evidence base already in existence for improvement in survival and will serve as a baseline for future audits in this area.

Entities:  

Mesh:

Year:  2003        PMID: 14696819      PMCID: PMC2475416     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN: 0041-6193


  6 in total

1.  Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients.

Authors:  E J Junor; D J Hole; L McNulty; M Mason; J Young
Journal:  Br J Obstet Gynaecol       Date:  1999-11

2.  Management and survival of ovarian cancer patients in south east England.

Authors:  C D Wolfe; K Tilling; K S Raju
Journal:  Eur J Cancer       Date:  1997-10       Impact factor: 9.162

3.  What changes in the organisation of cancer services will improve the outcome for women with ovarian cancer?

Authors:  C Woodman; A Baghdady; S Collins; J A Clyma
Journal:  Br J Obstet Gynaecol       Date:  1997-02

4.  Management of ovarian cancer: referral to a multidisciplinary team matters.

Authors:  E J Junor; D J Hole; C R Gillis
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

5.  An audit of primary surgical treatment for women with ovarian cancer referred to a cancer centre.

Authors:  P S Sengupta; G C Jayson; R J Slade; A Eardley; J A Radford
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

6.  The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma.

Authors:  S Kehoe; J Powell; S Wilson; C Woodman
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.